Hemodynamic Monitoring Devices Market To Reach $2.78 Billion By 2033

Hemodynamic Monitoring Devices Market Growth & Trends

The global hemodynamic monitoring devices market size is expected to reach USD 2.78 billion by 2033 and expand at a CAGR of 6.5% from 2025 to 2033, based on a new report by Grand View Research, Inc. The growth of the market is attributed to the growing cases of cardiovascular diseases (CVD) such as ischemic stroke, heart failure, and others. Moreover, the growing geriatric population across the globe propels the demand for hemodynamic monitoring devices.

According to OECD’s report in 2021, the life expectancy in lower-and-middle income Asian countries has increased by six years from 2000, while upper-middle-income countries have recorded a growth of four years in life expectancy. Moreover, by 2050 ten countries in Asia-Pacific are expected to be profiled as “aging societies,” while eleven countries are expected to be “super-aged societies.” In addition, NCBI estimated that more than half of CVD cases are recorded in the Asia-Pacific region.

The pandemic positively impacted the hemodynamic monitoring systems market. Many hospitals stated increased demand for hemodynamic monitoring during the pandemic due to COVID-19-induced symptoms. Hemodynamic monitoring devices were necessary to monitor cardiac function and blood flow in COVID-19 patients experiencing respiratory complications, as respiratory and cardiovascular systems are closely interconnected. In addition, sepsis & septic shock caused hemodynamic instability in COVID-19 patients; thereby, hemodynamic monitoring devices use was necessitated in hospitals and other care facilities.

In addition, the market for hemodynamic monitoring devices is aided by various strategic initiatives, such as venture capital funding. For instance, in July 2022, Retia Medical received USD 15 million in Series B funding to expand its commercial offerings and accelerate the development & commercialization of Argos hemodynamic monitor.

 Request a free sample copy or view report summary: Hemodynamic Monitoring Devices Market Report

Hemodynamic Monitoring Devices Market Report Highlights

• The non-invasive segment dominated the market with a 55.6% share in 2024.

• The monitors segment led the hemodynamic monitoring devices market, with the largest revenue share of 60.44% in 2024.

• The hospitals dominated the hemodynamic monitoring devices market in 2024. This can be attributed to the increasing prevalence of chronic diseases, such as heart failure, respiratory disorders, and sepsis, which require close monitoring of hemodynamic parameters.

• North America dominated the global hemodynamic monitoring devices market with the largest revenue share of 40.99% in 2024.

Hemodynamic Monitoring Devices Market Segmentation

Grand View Research has segmented the global hemodynamic monitoring devices market on the basis of system type, product, end use, and region:

Hemodynamic Monitoring Devices System Type Outlook (Revenue, USD Million, 2021 - 2033)

• Invasive

• Minimally Invasive

• Non-Invasive

Hemodynamic Monitoring Devices Product Outlook (Revenue, USD Million, 2021 - 2033)

• Disposables

• Monitors

Hemodynamic Monitoring Devices End Use Outlook (Revenue, USD Million, 2021 - 2033)

• Hospitals

• Catheterization Labs

• Other

Hemodynamic Monitoring Devices Regional Outlook (Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Sweden

  • Denmark

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players of Hemodynamic Monitoring Devices Market

• BD

• GE HealthCare

• Baxter

• ICU Medical, Inc.

• Koninklijke Philips N.V.

• Masimo Corporation

• Deltex Medical Limited

• Getinge

• Nihon Kohden Corporation

• OSYPKA MEDICAL

• Schwarzer Cardiotek GmbH

• Caretaker Medical

• Medtronic

• Retia Medical Systems, Inc.

• Sramek BioDynamics, Inc.